Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LSI INDUSTRIES INCLYTS · Entity 5205 | EVP, HR and General Counsel | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LSI INDUSTRIES INC
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 165,460 |
Reported balance
After 2026-09-30 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 1,808 · Balance 165,460 F1: Common shares acquired in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan during the quarter ended September 30, 2026 at prices ranging from $20.23 to $25.17. |
| Common SharesSEC Table I · non-derivative | Direct | 73,109 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 73,109 |
Filing footnotes · ownership attribution and instrument terms
F1: Common shares acquired in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan during the quarter ended September 30, 2026 at prices ranging from $20.23 to $25.17.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PharMerica CORP
Report date December 07, 2017 · Filed December 08, 2017
Section 16 reporting ended · disclosed 2017-12-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-12-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-11-20 · Gift · Disposed 2,753 · Balance 87,023 Row 2 · 2017-12-07 · Disposition to issuer · Disposed 87,023 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 1, 2017 (the "Merger Agreement"), by and among PharMerica Corporation (the "Company"), Phoenix Parent Holdings Inc., a Delaware corporation ("Parent"), and Phoenix Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent, at the effective time ("Effective Time") of the merger, Merger Sub will merge with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent. F2: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. |
| Performance share unitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 29,672 |
Reported balance
After 2017-12-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-12-07 · Grant · Acquired 29,672 · Balance 29,672 F2: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. |
| Performance share unitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-12-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-12-07 · Disposition to issuer · Disposed 29,672 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.84 · Expires 2018-03-25 | Direct | 0 |
Reported balance
After 2017-12-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-12-07 · Disposition to issuer · Disposed 9,588 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each outstanding employee option, whether vested or unvested ("Company Stock Option") became fully vested and was converted automatically into the right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such Company Stock Option, multiplied by (y) the excess, if any, of the Merger Consideration over the exercise price per share of such Company Stock Option. F3: The options vested in the following amounts on the following dates: 9,588 options on 03/25/2012, 9,588 options on 03/25/2013, 9,588 options on 03/25/2014 and 9,588 options on 03/25/2015. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 1, 2017 (the "Merger Agreement"), by and among PharMerica Corporation (the "Company"), Phoenix Parent Holdings Inc., a Delaware corporation ("Parent"), and Phoenix Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent, at the effective time ("Effective Time") of the merger, Merger Sub will merge with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent.
F2: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration.
F3: The options vested in the following amounts on the following dates: 9,588 options on 03/25/2012, 9,588 options on 03/25/2013, 9,588 options on 03/25/2014 and 9,588 options on 03/25/2015.
F4: Pursuant to the Merger Agreement, at the Effective Time, each outstanding employee option, whether vested or unvested ("Company Stock Option") became fully vested and was converted automatically into the right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such Company Stock Option, multiplied by (y) the excess, if any, of the Merger Consideration over the exercise price per share of such Company Stock Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2021 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,242 | $8.55 | $10,619.10 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 21 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,232 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| March 12, 2021 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,026 | $10.42 | $10,690.92 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 20 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,990 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| February 26, 2021 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,177 | $9.02 | $10,616.54 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 19 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,964 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| February 12, 2021 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,116 | $9.58 | $10,691.28 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 18 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,787 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| January 29, 2021 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,106 | $9.60 | $10,617.60 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 17 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,671 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| January 15, 2021 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,226 | $8.72 | $10,690.72 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 16 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,565 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| December 31, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,240 | $8.56 | $10,614.40 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 15 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,339 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| December 18, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,178 | $9.01 | $10,613.78 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 14 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,099 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| December 04, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,329 | $7.99 | $10,618.71 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 13 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,921 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| November 20, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,352 | $7.85 | $10,613.20 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 12 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,592 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| November 06, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,481 | $7.17 | $10,618.77 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 11 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,240 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| October 23, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,439 | $7.38 | $10,619.82 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 10 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,759 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| October 09, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,427 | $7.48 | $10,673.96 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 9 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,320 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| September 30, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 11,259 | $6.75 | $75,998.25 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 8 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,893 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| September 25, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,654 | $6.42 | $10,618.68 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 7 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,634 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| September 11, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,681 | $6.35 | $10,674.35 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 6 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,980 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| August 28, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,519 | $6.99 | $10,617.81 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 5 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,299 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 19:45 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantOption to Buy · Derivative | 21,928 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001567619-20-015800 · doc1.xml · derivative · entry 5 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,928 Underlying: Common Shares · 21,928 shares Expires 2030-08-19 F4 · derivative.exercise_date: The options vest ratably over a three year period. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 19:45 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Shares | 10,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-015800 · doc1.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,654 Read SEC document |
| August 14, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,625 | $6.57 | $10,676.25 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 4 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,780 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| August 07, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 635 | $6.69 | $4,248.15 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 3 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,155 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| July 17, 2020 Filed Aug 13, 2021 13:57 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,785 | $5.98 | $10,674.30 |
DisclosureSEC source: 0001567619-21-015354 · doc1.xml · nonDerivative · entry 2 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,520 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| June 19, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,694 | $6.30 | $10,672.20 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 13 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,735 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| June 05, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,656 | $6.41 | $10,614.96 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 12 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,041 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| May 22, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,788 | $5.97 | $10,674.36 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 11 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,384 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| May 08, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 869 | $6.11 | $5,309.59 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 10 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,596 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| April 24, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,576 | $5.77 | $9,093.52 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 9 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,727 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| April 09, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 2,469 | $4.30 | $10,616.70 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 8 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,152 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| March 27, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 2,895 | $3.69 | $10,682.55 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 7 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,682 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| March 13, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 2,596 | $4.09 | $10,617.64 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 6 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,787 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| February 28, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,609 | $6.64 | $10,683.76 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 5 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,191 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| February 14, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,552 | $6.84 | $10,615.68 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 4 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,582 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| January 31, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,597 | $6.65 | $10,620.05 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 3 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,030 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| January 17, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,699 | $6.29 | $10,686.71 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 2 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,433 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| January 03, 2020 Filed Aug 14, 2020 13:49 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantCommon Stock | 1,735 | $6.12 | $10,618.20 |
DisclosureSEC source: 0001567619-20-015214 · doc1.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,735 F1 · security: Common Shares held in the LSI Industries Inc. Non-Qualified Deferred Compensation Plan. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 20:48 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantOption to Buy · Derivative | 73,404 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001567619-19-017535 · doc1.xml · derivative · entry 3 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,404 Underlying: Common Shares · 73,404 shares Expires 2029-08-21 F3 · derivative.exercise_date: The options vest ratably over a three year period. Read SEC document |
| August 05, 2019 Filed Aug 5, 2019 20:34 UTC | LSI INDUSTRIES INC LYTS · Entity 5205 | GrantOption to Buy · Derivative | 100,000 | $0.00 Strike: $4.04 | $0.00 |
DisclosureSEC source: 0001567619-19-015804 · doc1.xml · derivative · entry 2 Caneris Thomas A · CIK 0001409783 · Sr. VP, HR and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2029-08-05 F1 · derivative.exercise_date: Non-qualified stock option granted pursuant to the Employment Offer Letter dated June 13, 2019 between the Reporting Person and the Issuer as an inducement award outside the Issuer's 2012 Stock Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The option vests as follows: 100,000 shares on August 5, 2022. The vesting of the option is subject to the Reporting Person's continued employment with the Issuer as Senior Vice President, Human Resources and General Counsel on August 5, 2022. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:57 UTC | PharMerica CORP PMC · Entity 171237 | Disposition to issuerEmployee Stock Option · Derivative | 9,588 | $18.41 Strike: $10.84 | $176,515.08 |
DisclosureSEC source: 0001209191-17-064755 · doc4.xml · derivative · entry 5 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 9,588 shares Expires 2018-03-25 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding employee option, whether vested or unvested ("Company Stock Option") became fully vested and was converted automatically into the right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such Company Stock Option, multiplied by (y) the excess, if any, of the Merger Consideration over the exercise price per share of such Company Stock Option. F3 · derivative.exercise_date: The options vested in the following amounts on the following dates: 9,588 options on 03/25/2012, 9,588 options on 03/25/2013, 9,588 options on 03/25/2014 and 9,588 options on 03/25/2015. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:57 UTC | PharMerica CORP PMC · Entity 171237 | Disposition to issuerPerformance share units · Derivative | 29,672 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-17-064755 · doc4.xml · derivative · entry 4 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 29,672 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. F2 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:57 UTC | PharMerica CORP PMC · Entity 171237 | GrantPerformance share units · Derivative | 29,672 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-17-064755 · doc4.xml · derivative · entry 3 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,672 Underlying: Common Stock, $0.01 par value · 29,672 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. F2 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:57 UTC | PharMerica CORP PMC · Entity 171237 | Disposition to issuerCommon Stock, $0.01 par value | 87,023 | $29.25 | $2,545,422.75 |
DisclosureSEC source: 0001209191-17-064755 · doc4.xml · nonDerivative · entry 2 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 1, 2017 (the "Merger Agreement"), by and among PharMerica Corporation (the "Company"), Phoenix Parent Holdings Inc., a Delaware corporation ("Parent"), and Phoenix Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent, at the effective time ("Effective Time") of the merger, Merger Sub will merge with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent. F2 · price: Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) a portion of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into shares of Parent common stock, par value $0.01 per share; (ii) the remaining shares of Company Common Stock owned by the reporting person were converted into the right to receive $29.25 in cash without interest (the "Merger Consideration"); and (iii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration. Read SEC document |
| November 20, 2017 Filed Dec 8, 2017 21:57 UTC | PharMerica CORP PMC · Entity 171237 | GiftCommon Stock, $0.01 par value | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064755 · doc4.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,023 Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 21:14 UTC | PharMerica CORP PMC · Entity 171237 | Tax withholdingCommon Stock, $0.01 par value | 1,541 | $23.60 | $36,367.60 |
DisclosureSEC source: 0001209191-17-023162 · doc4.xml · nonDerivative · entry 2 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,778 Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 21:14 UTC | PharMerica CORP PMC · Entity 171237 | GrantCommon Stock, $0.01 par value | 4,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-023162 · doc4.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,319 Read SEC document |
| March 24, 2017 Filed Apr 11, 2017 20:59 UTC | PharMerica CORP PMC · Entity 171237 | GrantCommon Stock, $0.01 par value | 9,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026583 · doc4.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,776 Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 21:16 UTC | PharMerica CORP PMC · Entity 171237 | Tax withholdingCommon Stock, $0.01 par value | 982 | $23.15 | $22,733.30 |
DisclosureSEC source: 0001209191-17-022081 · doc4.xml · nonDerivative · entry 2 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,066 Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 21:16 UTC | PharMerica CORP PMC · Entity 171237 | Tax withholdingCommon Stock, $0.01 par value | 1,374 | $22.50 | $30,915.00 |
DisclosureSEC source: 0001209191-17-022081 · doc4.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,048 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:13 UTC | PharMerica CORP PMC · Entity 171237 | Tax withholdingCommon Stock, $0.01 par value | 1,239 | $23.00 | $28,497.00 |
DisclosureSEC source: 0001209191-17-020781 · doc4.xml · nonDerivative · entry 1 Caneris Thomas A · CIK 0001409783 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,422 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.